Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus - "Flatbush diabetes"

Journal of Pediatric Endocrinology and Metabolism

Volumn 15, Issue SUPPL. 1, 2002, Pages 493-501

  Banerji, Mary Ann ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

cell recovery; C peptide; Cell function; Children; Glucagon; Insulin; Remission; Type 2 diabetes mellitus

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; DIAGNOSTIC AGENT;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; BODY MASS; CELL FUNCTION; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC KETOACIDOSIS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ETHNIC GROUP; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN DEFICIENCY; INSULIN RESISTANCE; MEDICAL DECISION MAKING; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; REMISSION; TEST MEAL; TREATMENT PLANNING; ADULT; BLOOD; FOOD; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; PANCREAS ISLET; PATHOPHYSIOLOGY; PUBERTY; REVIEW; SECRETION;

ADOLESCENT; ADULT; BODY MASS INDEX; C-PEPTIDE; CHILD; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FOOD; GLUCAGON; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; NEGROID RACE; PUBERTY; AFRICAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; HUMANS;

EID: 0036012944     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Emerging epidemic of type 2 diabetes in youth
2. Non-insulin dependent diabetes mellitus in childhood and adolescence
3. Increasing obesity in children
4. Type 2 diabetes in children and adolescents
5. Quantification of the relationship between insulin sensitivity and B-cell function in human subjects: Evidence for a hyperbolic function
6. Diminished B cell secretory capacity in patients with non-insulin dependent diabetes mellitus
7. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance
8. Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: Outcome of a prospective study in postmenopausal Caucasian women
9. Insulin action in black Americans with non-insulin dependent diabetes mellitus
10. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests
11. Beta cell dysfunction induced by chronic hyperglycemia
12. Lipotoxicity of the pancreatic beta cell is associated with glucose dependent esterification of fatty acids into neutral lipids
13. The importance of beta cell failure in the development and progression of type 2 diabetes
14. Insulin sensitive and insulin resistant variants in NIDDM
15. Overview of 6 years' therapy in type 2 diabetes: A progressive disease
16. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
17. Beta cell deterioration determines the onset and rate of progression of secondary dietary failure and type 2 diabetes mellitus. The 10 year follow up of the Belfast Diet Study
18. Increased insulin secretion in puberty: A compensatory response to reductions in insulin sensitivity
19. Correlations between fatty acids and glucose metabolism: Potential explanation of insulin resistance of puberty
20. Co-existence of severe insulin resistance and hyperinsulinemia in pre-adolescent obese children
21. Insulin resistance in childhood obesity
22. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes
23. Non-insulin dependent diabetes mellitus in African-American youths of Arkansas
24. Black-white contrasts in insulin levels during pubertal development. The Bogalusa Heart Study
25. Obesity and cardiovascular risk factors in black and white girls: The NHLBI Growth and Health Study
26. Differences in the in vivo insulin secretion and sensitivity in healthy black and white adolescents
27. Insulin secretion and sensitivity in healthy black versus white prepubertal healthy children
28. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study
29. Do Blacks with NIDDM have an insulin-resistance syndrome?
30. The relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects
31. Insulin sensitivity in African American children with and without family histories of type 2 diabetes
32. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative
33. Glucose intolerance in obese adolescents with polycystic ovary syndrome: Role of insulin resistance and beta cell dysfunction and risk of cardiovascular disease
34. C-peptide and glucagon profiles in minority patients with type 2 diabetes
35. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus
36. C-peptide and insulin responses to glucose load in minority children with type 2 diabetes mellitus
37. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance
38. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects
39. Insulin responses to non-glucose stimuli in non-insulin dependent diabetes mellitus during a tolbutamide infusion
40. Potentiation of insulin secretory responses by plasma glucose level in man: Evidence that hyperglycemia in man compensates for impaired glucose potentiation
41. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment
42. Induction of remission in newly diagnosed black NIDDM patients
43. Remission in non-insulin dependent diabetes mellitus: Clinical characteristics of remission and relapse in black patients
44. Long term remission in NIDDM in blacks
45. Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises
46. Effects of early introduction of intensive insulin therapy on the clinical course of non-obese NIDDM patients
47. Induction of long term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment
48. Diabetes, insulin secretion and the pancreatic beta cell
49. GAD antibody negative NIDDM in Black subjects with DKA and increased frequency of HLA DR3 and DR4. Flatbush diabetes
50. Glucagon and the A cell: Physiology and pathophysiology. Part 1
51. Glucagon and the A cell: Physiology and pathophysiology. Part 2
52. Impact of lack of suppression of glucagon on glucose tolerance in humans
53. Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in post menopausal women with impaired glucose tolerance